Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

KRYSKRYS
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Krystal Biotech, Inc.

GEODE CAPITAL MANAGEMENT, LLC holds 698,993 shares of KRYS (Krystal Biotech, Inc.), worth $259.8M as of 2026-Q2. The position was increased (+8.5% shares). KRYS represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$259.8M

Current Shares

698,993

Total Value Change

+$152.1M

Total Shares Change

+107,362

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
698,993
+8.5%
$259.8M0.0%$371.67
33
2026-Q1
Increased
643,975
+5.3%
$166.4M0.0%$263.80
32
2025-Q4
Increased
611,878
+0.1%
$150.9M0.0%$247.88
30
2025-Q3
Decreased
611,244
-1.3%
$107.9M0.0%$176.75
0
2025-Q2
Increased
619,547
+1.2%
$85.2M0.0%$138.88
30
2025-Q1
Increased
612,353
+3.5%
$110.4M0.0%$183.92
31
2024-Q4
Decreased
591,596
-0.0%
$92.7M0.0%$159.80
0
2024-Q3
Increased
591,631
+2.0%
$107.7M0.0%$177.14
31

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used